Cladribine for highly active relapsing multiple sclerosis

Cladribine (Mavenclad) is a new oral treatment for adults with highly active relapsing multiple sclerosis. This article summarises its dosing and monitoring requirements, efficacy in the CLARITY trial and place in therapy.

Read the full article.

Add yours ↓
Web design and marketing agency Leamington Spa